Navigation Links
Bionovo Notified by NASDAQ of Minimum Bid Price Deficiency
Date:9/21/2009

EMERYVILLE, Calif., Sept. 21 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) today announced that on September 15, 2009, the company received a letter from NASDAQ stating that, for the last 30 consecutive business days, the bid price of its common stock has closed below the minimum $1.00 per share requirement for continued listing on the NASDAQ Capital Market. The letter further stated that the company has been provided a period of 180 calendar days, or until March 15, 2010, to regain compliance. If, at anytime before March 15, 2010, the bid price of the common stock closes at $1.00 per share or more for a minimum of 10 consecutive business days, NASDAQ has indicated that it will provide written notification that compliance has been regained.

The deficiency letter has no effect on the listing of the company's common stock at this time and its common stock will continue to trade on the NASDAQ Capital Market under the symbol "BNVI."

In the event the Company does not regain compliance with the rule prior to the expiration of the period, it will receive written notification that its securities are subject to delisting. Alternatively, the Company may be eligible for an additional grace period if it meets the initial listing standards, with exception of bid price, for the NASDAQ Capital Market. If it meets the initial listing criteria, NASDAQ staff will notify the Company that it has been granted an additional 180 calendar day compliance period.

Bionovo intends to use its best efforts to regain compliance with NASDAQ's minimum bid requirement.

For further information on the relevant NASDAQ rules, please consult NASDAQ Listing Rules 5550(a)(2) - bid price, 5810(c)(3)(A) - grace period, 5810(b) - public disclosure, and 5505 - Ca
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Bionovo to Present Positive Results from Phase 2 Trial of Menerba for Vasomotor Symptoms to the International Community
2. Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer
3. Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference
4. Bionovo Announces Arbitration Decision in Lawsuit Filed by Former Officer - All Claims Denied
5. Bionovo, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Thursday, May 7, 2009
6. Bionovo to Present at the Cambria Capital Investor Meeting
7. Bionovo to Present at Wall Street Analyst Forums 20th Annual Institutional Investor Conference
8. Bionovo, Inc. to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 12, 2009
9. Jan Ake Gustafsson, M.D., Ph.D., Joins Bionovos Scientific Advisory Board
10. Bionovo Announces Presentation at the National Cancer Institute
11. Bionovo Announces Cost Control Measures Taken
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 05, 2015 Leveraging the industry-leading technology ... Greece, an experienced team of fertility specialists are committed ... patients around the globe. , “We’re honored that Maternity ... remains a global leader in reproductive medicine. The clinic ... specialists in the world who play an important role ...
(Date:5/5/2015)... PA (PRWEB) May 05, 2015 The 2015 ... raised $110,000 to benefit their global research, outreach and patient ... silent auction, and awards ceremony that attracted hundreds of supporters. ... of the discovery of the hepatitis B virus (HBV) by ... Blumberg received the Nobel Prize in Medicine for his discovery ...
(Date:5/5/2015)... 05, 2015 Viverae®, a health ... Inc., a leading multinational developer, manufacturer and marketer ... of vascular, urology, oncology and surgical specialty products, ... The Vanguard Award recognizes outstanding achievement in ... among Viverae’s significant client base. , Viverae reviewed ...
(Date:5/5/2015)... Sunny skies and cool temperatures made for great ... runners and walkers participated in Global Lyme Alliance’s (GLA) inaugural ... , The 5K and 10K runs and 1-and 3-mile walks ... raise funds for tick-borne disease research. The “Lyme Walk and ... merger of Lyme Research Alliance (LRA) and Tick-Borne Disease ...
(Date:5/5/2015)... 05, 2015 Skedans Systems ... BC announced the Skedans Sensor Collaboration Platform at ... and web app developers, provides tooling to deliver real ... sensors. , The Skedans Sensor Collaboration Platform is a ... the Internet of Things, Web Real Time Communications (WebRTC), ...
Breaking Medicine News(10 mins):Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2
... Treat Diseases (HTDS) www.htdsmedical.com is pleased to ... Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (Mellow Hope). ... corporation; HTDS Enterprises, Inc., which is the parent company ... million USD on an all-stock basis. The company will ...
... Misonix, Inc. (Nasdaq: MSON ), a developer ... Europe is used for the ablation of tumors and ... a new, three year, exclusive distribution agreement with privately-held ... Saba, Israel, for the distribution of the SonaStar(TM) Ultrasonic ...
... Consumer Watchdog sent a letter to Senator ... expressing their profound disappointment that consumer advocates had ... the Massachusetts senator to formulate health care reform ... recent national polls showing the public overwhelming opposed ...
... Well Asthma is Controlled in New EnglandPROVIDENCE, R.I., Feb. ... (ALANE) has partnered with QualityMetric Incorporated of Lincoln, Rhode ... that will help asthma sufferers learn how well their ... the results with their physician.The Asthma Control Test(TM) (ACT(TM)) ...
... QINGDAO, China and ROCKVILLE, Md., Feb. 20 ... SYUT , "Synutra"), a leading infant formula,company ... seller of nutritional products,for infants, children and ... of certain production permit numbers in a ...
... Inc., (OTC Bulletin Board: EFSF) an emerging healthcare ... dermatology, environmental and nutraceutical products, outlined its growth ... 2010 during its regularly scheduled monthly investor call, ... intends to increase revenues by improving the visibility ...
Cached Medicine News:Health News:Hard To Treat Diseases (HTDS) Closes Acquisition of Mellow Hope, China 2Health News:Hard To Treat Diseases (HTDS) Closes Acquisition of Mellow Hope, China 3Health News:Misonix Announces New Distribution Agreement for Israel 2Health News:Misonix Announces New Distribution Agreement for Israel 3Health News:Consumer Watchdog to U.S. Senate: Don't Leave Consumers Out of Health Reform Debate, Public Opposes Mandatory Purchases of Private Insurance & Supports Opening Medicare to Everyone 2Health News:American Lung Association of New England Launches Online Asthma Control Test 2Health News:American Lung Association of New England Launches Online Asthma Control Test 3Health News:American Lung Association of New England Launches Online Asthma Control Test 4Health News:Synutra Issues Statement Regarding Market Rumors on Revocation of its Production Certification 2Health News:Synutra Issues Statement Regarding Market Rumors on Revocation of its Production Certification 3Health News:eFoodSafety.com Provides Revenue Guidance for FY 2010 2Health News:eFoodSafety.com Provides Revenue Guidance for FY 2010 3
(Date:5/5/2015)... May 5, 2015 (Family Features) Which health ... you,re like most adults, monitoring your weight, cholesterol, and ... routine. But what about vision care? ... adults reach their 40s, they often start to notice ... daily lives and job performance. Whether having difficulty reading ...
(Date:5/5/2015)... LOUIS and NIJMEGEN, the ... EndoStim, a medical device company developing lower esophageal ... (GERD) announced long-term, 3-year, positive safety and efficacy ... reflux symptoms of both heartburn and regurgitation and ... esophageal pH test) with near-complete elimination of dependence ...
(Date:5/5/2015)... SAN FRANCISCO , May 5, 2015  IQPC,s ... is pleased to announce the chairman of the Summit Mr. ... at Wipro. He will be joined by the expert speaker ... and more this May 11 – 12, at The Hotel ... The agenda is available for download on the event ...
Breaking Medicine Technology:Eye Care as You Age 2Eye Care as You Age 3Eye Care as You Age 4Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: